Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|December 14, 2022
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT TrialJ Michael Wells, Gerard J Criner, David M G Halpin, et al.
Respiratory Research|September 25, 2023
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyAfisi S Ismaila, Kieran J Rothnie, Robert P Wood, et al.
The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
The European Respiratory Journal|October 28, 2024
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPDR Chad Wade, Fernando J Martinez, Gerard J Criner, et al.
ERJ Open Research|March 11, 2021
Blood eosinophil count predicts treatment failure and hospital readmission for COPDMarjan Kerkhof, Isha Chaudhry, Ian D Pavord, et al.
ERJ Open Research|June 10, 2021
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practiceDavid M G Halpin, Sally Worsley, Afisi S Ismaila, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 1, 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID TrialDavid M G Halpin, Robyn Kendall, Soham Shukla, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 3, 2022
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care SettingDavid M G Halpin, Kieran J Rothnie, Victoria Banks, et al.
Advances in Therapy|July 20, 2022
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-AnalysisAfisi S Ismaila, Katrin Haeussler, Alexandrosz Czira, et al.
Advances in Therapy|July 18, 2022
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-AnalysisAfisi S Ismaila, Katrin Haeussler, Alexandrosz Czira, et al.
Pageof 15